Genomic Profiling of Genetic and Rare Diseases

NARecruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

February 28, 2030

Conditions
Rare DiseasesGenetic Disease
Interventions
GENETIC

Whole Exome Sequencing (WES)

Blood samples, buccal swabs, and pathological tissue samples (skin/muscle) will be collected, and subsequently, DNA extracted from those tissues will be used for genomic analysis using Whole Exome Sequencing. The sample will follow the diagnostic pipeline already established inside the hospital. Moreover, the remaning aliquots of DNA extracted from the tissue (peripheral blood or tissue specimen) will be sent by the Genomics core facility to the Biobank for storage upon analysis completion.

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC PEDIATRIA, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER